Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

As medicine targets personal DNA profiles, York researchers examine ethics and patient experiences

05.08.2004


Researchers at the University of York are beginning a major study into the ethical and personal issues raised by a potential revolution in healthcare, which could incorporate individualised medical care – pharmacogenetics - into clinical practice.



The use of genetic testing as a routine part of medical treatment opens exciting horizons, but brings with it the responsibility to understand the concerns individuals may have about DNA sampling, and about wider issues such as the possible impact of genetic information. Much of the science of pharmacogenetics is known, but there are many potential hurdles to overcome before the technology is introduced into routine medical use.

Over the next three years Professor Andrew Webster, Dr Graham Lewis and a team in the Science and Technology Studies Unit (SATSU) at York will work with colleagues across the UK monitoring patients’ reactions to warfarin, commonly used to prevent blood clots. The team from York will interview some of the 2,400 patients who will be selected for the study. Of the 2,400 patients, 2000 will be hospital-based and 400 will be recruited through GP surgeries as warfarin can be prescribed by GPs.


Patients’ responses will be mapped against their personal DNA profiles and the SATSU team will interview them to see how they feel about DNA samples being taken, and how publicly acceptable this would be, and the hurdles to introducing the technique.

Warfarin is a very useful drug currently taken by 600,000 patients in the UK, but a small proportion of those who take it suffer serious side effects, even sometimes death. If a patient’s genetic makeup is known beforehand, doctors can prescribe far more accurately so that there are fewer serious side effects.

But the serious ethical issues to be considered, such as reading individual genetic codes from DNA samples, affect both patients and the clinical staff who will have to introduce the new and complex technologies. Clinical staff experiences of these processes are also examined through interviews. Dr Lewis commented; “it is important to study how attitudes and perceptions change with the introduction of new medical technologies like pharmacogenetics, and that means studying the experiences of doctors and nursing staff as well as patients.”

Dr Lewis added: “It’s been known for a long time that an individual’s genetic make-up affects the way they respond to medicines, both in terms of the likelihood of adverse side effects, and whether they respond to treatment. Pharmacogenetics, or so-called personalised medicine, offers the exciting possibility of individualised treatment.

“This could revolutionise medical care, giving doctors the ability to prescribe the best drug for their patient without trial and error. “But there are major considerations – confidentiality, the impact of the genetic information on the patient, and the implications for their families. “We need to understand how people will view this new development.

“There are also cost implications – is it worthwhile introducing pharmacogenetics? There is no real evidence yet from large-scale trials. We need to recognise that many other factors such as diet, lifestyle and age affect a patient’s response to warfarin treatment.”

The genetic profiling of patients taking part in the study will not influence their own treatment but will hopefully help future warfarin users.

The teams involved in the study will share £840,000 in research funding from the Department of Health.

Dr Graham Lewis | alfa
Further information:
http://www.york.ac.uk

More articles from Health and Medicine:

nachricht One gene closer to regenerative therapy for muscular disorders
01.06.2017 | Cincinnati Children's Hospital Medical Center

nachricht The gut microbiota plays a key role in treatment with classic diabetes medication
01.06.2017 | University of Gothenburg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Quantum thermometer or optical refrigerator?

23.06.2017 | Physics and Astronomy

A 100-year-old physics problem has been solved at EPFL

23.06.2017 | Physics and Astronomy

Equipping form with function

23.06.2017 | Information Technology

VideoLinks
B2B-VideoLinks
More VideoLinks >>>